Genetic Basis of Early Onset Atrial Fibrillation in Patients without Risk Factors
- PMID: 36975868
- PMCID: PMC10057774
- DOI: 10.3390/jcdd10030104
Genetic Basis of Early Onset Atrial Fibrillation in Patients without Risk Factors
Abstract
Background: Atrial fibrillation (AF) is the most common arrhythmia and typically occurs in elderly patients with other cardiovascular and extracardiac diseases. However, up to 15% of AF develops without any related risk factors. Recently, the role of genetic factors has been highlighted in this particular form of AF.
Aims: The aims of this study were to determine the prevalence of pathogenic variants in early-onset AF in patients without known disease-related risk factors and to identify any structural cardiac abnormalities in these patients.
Materials and methods: We conducted exome sequencing and interpretation in 54 risk factor-free early-onset AF patients and further validated our findings in a similar AF patient cohort from the UK Biobank.
Results: Pathogenic/likely pathogenic variants were found in 13/54 (24%) patients. The variants were identified in cardiomyopathy-related and not arrhythmia-related genes. The majority of the identified variants were TTN gene truncating variants (TTNtvs) (9/13 (69%) patients). We also observed two TTNtvs founder variants in the analysed population-c.13696C>T p.(Gln4566Ter) and c.82240C>T p.(Arg27414Ter). Pathogenic/likely pathogenic variants were found in 9/107 (8%) individuals from an independent similar AF patient cohort from the UK Biobank. In correspondence with our Latvian patients, only variants in cardiomyopathy-associated genes were identified. In five (38%) of the thirteen Latvian patients with pathogenic/likely pathogenic variants, dilation of one or both ventricles was identified on a follow-up cardiac magnetic resonance scan.
Conclusions: We observed a high prevalence of pathogenic/likely pathogenic variants in cardiomyopathy-associated genes in patients with risk factor-free early-onset AF. Moreover, our follow-up imaging data indicate that these types of patients are at risk of developing ventricular dilation. Furthermore, we identified two TTNtvs founder variants in our Latvian study population.
Keywords: early-onset atrial fibrillation; genetics; next-generation sequencing; pathogenic variants.
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Schnabel R.B., Yin X., Gona P., Larson M.G., Beiser A.S., McManus D.D., Newton-Cheh C., Lubitz S.A., Magnani J.W., Ellinor P.T., et al. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: A cohort study. Lancet. 2015;386:154–162. doi: 10.1016/S0140-6736(14)61774-8. - DOI - PMC - PubMed
-
- Kloosterman M., Oldgren J., Conen D., Wong J.A., Connolly S.J., Avezum A., Yusuf S., Ezekowitz M.D., Wallentin L., Ntep-Gweth M., et al. Characteristics and outcomes of atrial fibrillation in patients without traditional risk factors: An RE-LY AF registry analysis. EP Eur. 2020;22:870–877. doi: 10.1093/europace/euz360. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
